TABLE 1.

Patient demographics and baseline characteristics

Demographic or baseline characteristicValue for:
Control patients (n = 12)Micafungin-treated patients (n = 62)
Gender
    No. of females (%)7 (58.3)42 (67.7)
Race
    No. of Caucasians (%)12 (100.0)50 (80.6)
Age (yr)
    Mean ± SD43.5 ± 11.6341.9 ± 11.32
    Range20-5619-65
Mean wt (kg) ± SD72.2 ± 13.9582.6 ± 19.35
Underlying disease (no. [%])
    Hematologic malignancy7 (58.3)35 (56.5)
    Solid tumor4 (33.3)24 (38.7)
    Other1 (8.3)3 (4.8)
Type of transplantation (no. [%])
    Allogeneic6 (50.0)26 (41.9)
    Autologous6 (50.0)36 (58.1)
Type of cells (no. [%])
    Bone marrow cells3 (25.0)8 (12.9)
    Peripheral stem cells8 (66.7)50 (80.6)
    Cord blood cells1 (8.3)4 (6.5)